SETDB1 induces lenalidomide resistance in multiple myeloma cells via epithelial‑mesenchymal transition and PI3K/AKT pathway activation-Reference-Cited by-同舟云学术

SETDB1 induces lenalidomide resistance in multiple myeloma cells via epithelial‑mesenchymal transition and PI3K/AKT pathway activation

Published:2023-04-21 Issue:6 Volume:25 Page:
ISSN:1792-0981
Container-title:Experimental and Therapeutic Medicine
language:
Short-container-title:Exp Ther Med

Author:

Qian Xiaoli¹,Yang Yang²,Deng Yingfen¹,Liu Yali¹,Zhou Yuwen¹,Han Fang²,Xu Yue¹,Yuan Hongjian¹

Affiliation:

1. Department of Hematology, The Second People's Hospital of Taizhou, Medical College of Yangzhou University, Jiangyan, Taizhou, Jiangsu 225500, P.R. China

2. Department of Gastroenterology, The Second People's Hospital of Taizhou, Medical College of Yangzhou University, Jiangyan, Taizhou, Jiangsu 225500, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Immunology and Microbiology (miscellaneous),General Medicine

Reference57 articles.

1. Multiple myeloma;Palumbo;N Engl J Med,2011

2. Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma;Benboubker;N Eng J Med,2014

3. Continuous lenalidomide treatment for newly diagnosed multiple myeloma;Palumbo;N Engl J Med,2012

4. Lenalidomide and high-dose dexamethasone compared with dexamethasone as initial therapy for multiple myeloma: A randomized Southwest oncology group trial (S0232);Zonder;Blood,2010

5. Proteomic profiling reveals CDK6 upregulation as a targetable resistance mechanism for lenalidomide in multiple myeloma;Ng;Nat Commun,2022

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging roles of non-coding RNAs in modulating the PI3K/Akt pathway in cancer;Non-coding RNA Research;2025-02

2. SETDB1, an H3K9-specific methyltransferase: An attractive epigenetic target to combat cancer;Drug Discovery Today;2024-05

3. SETDB1: Progress and prospects in cancer treatment potential and inhibitor research;Bioorganic Chemistry;2024-04

4. The SAGA acetyltransferase module is required for the maintenance of MAF and MYC oncogenic gene expression programs in multiple myeloma;2024-03-28